The Impact of Customized Screening Intervals on the Burden of Drug-Drug Interaction Alerts: An Interrupted Time Series Analysis von Van de Sijpe, Greet, Walgraeve, Karolien, Van Laer, Eva, Quintens, Charlotte, Machiels, Christophe, Foulon, Veerle, Casteels, Minne, Van der Linden, Lorenz, Spriet, Isabel

Volltext

The Impact of Customized Screening Intervals on the Burden of Drug-Drug Interaction Alerts: An Interrupted Time Series Analysis von Van De Sijpe, Greet, Walgraeve, Karolien, Van Laer, Eva, Quintens, Charlotte, Machiels, Christophe, Foulon, Veerle, Casteels, Minne, Van der Linden, Lorenz, Spriet, Isabel

Volltext

Regularity requirements in university course timetabling von De Cat, Broes, Machiels, Christophe, Janssens, Gerda, Denecker, Marc

Volltext bestellen

The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients von Van den Eynde, Marc, Mlecnik, Bernhard, Bindea, Gabriela, Fredriksen, Tessa, Church, Sarah E., Lafontaine, Lucie, Haicheur, Nacilla, Marliot, Florence, Angelova, Mihaela, Vasaturo, Angela, Bruni, Daniela, Jouret-Mourin, Anne, Baldin, Pamela, Huyghe, Nicolas, Haustermans, Karin, Debucquoy, Annelies, Van Cutsem, Eric, Gigot, Jean-Francois, Hubert, Catherine, Kartheuser, Alex, Remue, Christophe, Léonard, Daniel, Valge-Archer, Viia, Pagès, Franck, Machiels, Jean-Pascal, Galon, Jérôme

Volltext

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based t... von Machiels, Jean-Pascal H, Prof, Haddad, Robert I, MD, Fayette, Jérôme, MD, Licitra, Lisa F, MD, Tahara, Makoto, MD, Vermorken, Jan B, Prof, Clement, Paul M, Prof, Gauler, Thomas, MD, Cupissol, Didier, MD, Grau, Juan José, MD, Guigay, Joël, Prof, Caponigro, Francesco, MD, de Castro, Gilberto, PhD, de Souza Viana, Luciano, MD, Keilholz, Ulrich, Prof, del Campo, Joseph M, MD, Cong, Xiuyu Julie, PhD, Ehrnrooth, Eva, MD, Cohen, Ezra E W, MD

Volltext

Cancer risk in immune-mediated inflammatory diseases (IMID) von Beyaert, Rudi, Beaugerie, Laurent, Van Assche, Gert, Brochez, Lieve, Renauld, Jean-Christophe, Viguier, Manuelle, Cocquyt, Veronique, Jerusalem, Guy, Machiels, Jean-Pascal, Prenen, Hans, Masson, Pierre, Louis, Edouard, De Keyser, Filip

Volltext

Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD von De Preter, Vicky, Machiels, Kathleen, Joossens, Marie, Arijs, Ingrid, Matthys, Christophe, Vermeire, Severine, Rutgeerts, Paul, Verbeke, Kristin

Volltext

A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial von Galot, Rachel, Le Tourneau, Christophe, Saada-Bouzid, Esma, Daste, Amaury, Even, Caroline, Debruyne, Philip, Henry, Stéphanie, Zanetta, Sylvie, Rutten, Anemie, Licitra, Lisa, Canon, Jean-Luc, Kaminsky, Marie-Christine, Specenier, Pol, Rottey, Sylvie, Guigay, Joël, Kong, Anthony, Tinhofer, Inge, Borcoman, Edith, Dirix, Lieve, Raveloarivahy, Tiana, Fortpied, Catherine, Vanlancker, Maureen, Morfouace, Marie, Govaerts, Anne-Sophie, Machiels, Jean-Pascal

Volltext

Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040 von Harrington, Kevin J, Soulières, Denis, Le Tourneau, Christophe, Dinis, Jose, Licitra, Lisa F, Ahn, Myung-Ju, Soria, Ainara, Machiels, Jean-Pascal H, Mach, Nicolas, Mehra, Ranee, Burtness, Barbara, Ellison, Misoo C, Cheng, Jonathan D, Chirovsky, Diana Romana, Swaby, Ramona F, Cohen, Ezra E W

Volltext

Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial von Forget, Patrice, Bouche, Gauthier, Duhoux, Francois P, Coulie, Pierre G, Decloedt, Jan, Dekleermaker, Alain, Guillaume, Jean-Edouard, Ledent, Marc, Machiels, Jean-Pascal, Mustin, Véronique, Swinnen, Walter, van Maanen, Aline, Vander Essen, Lionel, Verougstraete, Jean-Christophe, De Kock, Marc, Berliere, Martine

Volltext

Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model von Gravis, Gwenaelle, Boher, Jean-Marie, Fizazi, Karim, Joly, Florence, Priou, Franck, Marino, Patricia, Latorzeff, Igor, Delva, Remy, Krakowski, Ivan, Laguerre, Brigitte, Walz, Jochen, Rolland, Fréderic, Théodore, Christine, Deplanque, Gael, Ferrero, Jean-Marc, Pouessel, Damien, Mourey, Loïc, Beuzeboc, Philippe, Zanetta, Sylvie, Habibian, Muriel, Berdah, Jean-François, Dauba, Jerome, Baciuchka, Marjorie, Platini, Christian, Linassier, Claude, Labourey, Jean-Luc, Machiels, Jean Pascal, El Kouri, Claude, Ravaud, Alain, Suc, Etienne, Eymard, Jean-Christophe, Hasbini, Ali, Bousquet, Guilhem, Soulie, Michel, Oudard, Stéphane

Volltext

Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer von Massard, Christophe, Chi, Kim Nguyen, Castellano, Daniel, de Bono, Johann, Gravis, Gwenaelle, Dirix, Luc, Machiels, Jean-Pascal, Mita, Alain, Mellado, Begoña, Turri, Sabine, Maier, Joan, Csonka, Denes, Chakravartty, Arunava, Fizazi, Karim

Volltext

Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer von Noortman, Wyanne A, Aide, Nicolas, Vriens, Dennis, Arkes, Lisa S, Slump, Cornelis H, Boellaard, Ronald, Goeman, Jelle J, Deroose, Christophe M, Machiels, Jean-Pascal, Licitra, Lisa F, Lhommel, Renaud, Alessi, Alessandra, Woff, Erwin, Goffin, Karolien, Le Tourneau, Christophe, Gal, Jocelyn, Temam, Stéphane, Delord, Jean-Pierre, van Velden, Floris H P, de Geus-Oei, Lioe-Fee

Volltext

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial von Gravis, Gwenaelle, Dr, Fizazi, Karim, Prof, Joly, Florence, Prof, Oudard, Stéphane, Prof, Priou, Franck, MD, Esterni, Benjamin, MSc, Latorzeff, Igor, MD, Delva, Remy, MD, Krakowski, Ivan, Prof, Laguerre, Brigitte, MD, Rolland, Fréderic, MD, Théodore, Christine, MD, Deplanque, Gael, MD, Ferrero, Jean Marc, Prof, Pouessel, Damien, MD, Mourey, Loïc, MD, Beuzeboc, Philippe, MD, Zanetta, Sylvie, MD, Habibian, Muriel, Berdah, Jean François, MD, Dauba, Jerome, MD, Baciuchka, Marjorie, MD, Platini, Christian, MD, Linassier, Claude, Prof, Labourey, Jean Luc, MD, Machiels, Jean Pascal, Prof, El Kouri, Claude, MD, Ravaud, Alain, Prof, Suc, Etienne, MD, Eymard, Jean Christophe, MD, Hasbini, Ali, MD, Bousquet, Guilhem, MD, Soulie, Michel, Prof

Volltext

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study von Cohen, Ezra E W, Soulières, Denis, Le Tourneau, Christophe, Dinis, José, Licitra, Lisa, Ahn, Myung-Ju, Soria, Ainara, Mach, Nicolas, Mehra, Ranee, Burtness, Barbara, Zhang, Pingye, Cheng, Jonathan, Swaby, Ramona F, Acosta-Rivera, Mirelis, Adkins, Douglas R., Aghmesheh, Morteza, Ahn, Myung-Ju, Airoldi, Mario, Aleknavicius, Eduardas, Al-Farhat, Yousuf, Algazi, Alain P., Almokadem, Salah, Alyasova, Anna, Bauman, Jessica R., Benasso, Marco, Berrocal, Alfonso, Bray, Victoria, Burtness, Barbara Ann, Caponigro, Francesco, Castro, Ana, Cescon, Terrence P., Chan, Kelvin, Chaudhry, Arvind, Chauffert, Bruno, Cohen, Ezra, De Boer, J.P., Dietz, Andreas, Dinis, Jose, Dupuis, Charlotte, Digue, Laurence, Escobar Alvarez, Yolanda, Evans, Mererid, Fidler, Mary Jo, Forster, Martin David, Friesland, Signe, Ganti, Apar K., Geoffrois, Lionnel, Grant, Cliona, Gruenwald, Viktor, Harrington, Kevin, Horvai, Geza, Inciura, Arturas, Jang, Raymond, Jankowska, Petra, Jimeno, Antonio, Joseph, Mano, Juarez Ramiro, Alejandro, Karaszewska, Boguslawa, Kawecki, Andrzej, Keilholz, Ulrich, Keller, Ulrich, Kocsis, Judit, Kotecki, Nuria, Kozloff, Mark F., Lambea, Julio, Landherr, Laszlo, Lantsukhay, Yuri, Lazarev, Sergey Alexandrovich, Lee, Lip Way, Le Tourneau, Christophe, Licitra, Lisa, Martincic, Danko, Matorin, Oleg Vladmirovhich, McGrath, Margaret, Machiels, Jean-Pascal, Mehra, Ranee, Misiukiewicz, Krzysztof, Morris, John C., Mufazalov, Fagim Fanisovich, Niu, Jiaxin, Pamoorthy Srinivasan, Devraj, Perez Segura, Pedro, Rauch, Daniel, Ribeiro, Maria Leonor, Rodriguez, Cristina, Rolland, Frederic, Russo, Antonio, Ruzsa, Agnes, Sanches, Frederico, Shin, Sang-Won, Shtiveland, Mikhail, Soulieres, Denis, Specenier, Pol, van Herpen, Carla M.L., Velez-Cortes, Hector A., Walsh, William V., Winterhalder, Ralph, Wojtukiewicz, Marek, Wong, Deborah, Zandberg, Dan

Volltext

Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Plati... von Machiels, Jean‐Pascal, Van Maanen, Aline, Vandenbulcke, Jean‐Marie, Filleul, Bertrand, Seront, Emmanuel, Henry, Stéphanie, D'Hondt, Lionel, Lonchay, Christophe, Holbrechts, Stéphane, Boegner, Petra, Brohee, Dany, Dequanter, Didier, Louviaux, Ingrid, Sautois, Brieuc, Whenham, Nicolas, Berchem, Guy, Vanderschueren, Brigitte, Fontaine, Christel, Schmitz, Sandra, Gillain, Aline, Schoonjans, Joelle, Rottey, Sylvie

Volltext

On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors von Morschhauser, Franck, Machiels, Jean-Pascal, Salles, Gilles, Rottey, Sylvie, Rule, Simon A. J., Cunningham, David, Peyrade, Frederic, Fruchart, Christophe, Arkenau, Hendrik-Tobias, Genvresse, Isabelle, Liu, Li, Koechert, Karl, Shen, Kui, Kneip, Christoph, Pena, Carol E., Grevel, Joachim, Zhang, Jun, Cisternas, Galia, Reschke, Susanne, Granvil, Camille, Awada, Ahmad

Volltext

Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the H... von Seront, Emmanuel, Schmitz, Sandra, Papier, Matthias, van Maanen, Aline, Henry, Stéphanie, Lonchay, Christophe, Rottey, Sylvie, van Caloen, Gabrielle, Machiels, Jean-Pascal

Volltext

Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castra... von Lavaud, Pernelle, Gravis, Gwenaëlle, Foulon, Stéphanie, Joly, Florence, Oudard, Stéphane, Priou, Frank, Latorzeff, Igor, Mourey, Loïc, Soulié, Michel, Delva, Remy, Krakowski, Ivan, Laguerre, Brigitte, Théodore, Christine, Ferrero, Jean Marc, Beuzeboc, Philippe, Habibian, Muriel, Rolland, Frédéric, Deplanque, Gael, Pouessel, Damien, Zanetta, Sylvie, Berdah, Jean François, Dauba, Jerome, Baciuchka, Marjorie, Platini, Christian, Linassier, Claude, Tubiana-Mathieu, Nicole, Machiels, Jean Pascal, Kouri, Claude El, Ravaud, Alain, Suc, Etienne, Eymard, Jean Christophe, Hasbini, Ali, Bousquet, Guilhem, Culine, Stéphane, Boher, Jean-Marie, Tergemina-Clain, Gabrielle, Legoupil, Clémence, Fizazi, Karim

Volltext

Extended Benefit from Sequential Administration of Docetaxel after Standard Fluorouracil, Epirubicin, and Cyclophosphamide Regimen for Node‐Positive Breast Cancer: The 8‐Year Follo... von Coudert, Bruno, Asselain, Bernard, Campone, Mario, Spielmann, Marc, Machiels, Jean‐Pascal, Pénault‐Llorca, Frédérique, Serin, Daniel, Lévy, Christelle, Romieu, Gilles, Canon, Jean‐Luc, Orfeuvre, Hubert, Piot, Gilles, Petit, Thierry, Jerusalem, Guy, Audhuy, Bruno, Veyret, Corinne, Beauduin, Marc, Eymard, Jean‐Christophe, Martin, Anne‐Laure, Roché, Henri

Volltext